Early and treatment-related deaths in childhood acute myeloid leukaemia in the Nordic countries: 1984-2003
Abstract Despite major improvements in the cure rate of childhood acute myeloid leukaemia (AML), 5-15% of patients still die from treatment-related complications. In a historical prospective cohort study, we analyzed frequency, clinical features and risk factors for early deaths (ED) and treatment-r...
Published in: | British Journal of Haematology |
---|---|
Language: | English |
Published: |
Wiley-Blackwell
2011
|
Subjects: | |
Online Access: | http://hdl.handle.net/2262/54894 https://doi.org/10.1111/j.1365-2141.2010.08389.x |
id |
fttrinitycoll:oai:tara.tcd.ie:2262/54894 |
---|---|
record_format |
openpolar |
spelling |
fttrinitycoll:oai:tara.tcd.ie:2262/54894 2023-05-15T16:49:07+02:00 Early and treatment-related deaths in childhood acute myeloid leukaemia in the Nordic countries: 1984-2003 2011-04-19T00:41:22Z http://hdl.handle.net/2262/54894 https://doi.org/10.1111/j.1365-2141.2010.08389.x en eng Wiley-Blackwell 0007-1048 (pISSN) 1365-2141 (eISSN) 00071048 (ISSN) BJH-2010-00926 (PII) BJH-2010-00926.R1 (manuscript) http://hdl.handle.net/2262/54894 British Journal of Haematology 151 5 447 doi:10.1111/j.1365-2141.2010.08389.x BJH (abbrev) 6 months Medicine 2011 fttrinitycoll https://doi.org/10.1111/j.1365-2141.2010.08389.x 2020-02-16T13:52:03Z Abstract Despite major improvements in the cure rate of childhood acute myeloid leukaemia (AML), 5-15% of patients still die from treatment-related complications. In a historical prospective cohort study, we analyzed frequency, clinical features and risk factors for early deaths (ED) and treatment-related deaths (TRD) in 525 children included in the Nordic protocols NOPHO-AML-84, -88 and -93. Seventy patients (13%) died before starting treatment or from treatment-related complications. The death rate rose from 11% in NOPHO-AML-84 to 29% in -88, but then fell to 8% in -93. Sixteen patients (3%) died within the first two weeks, mainly from bleeding or leukostasis. Hyperleukocytosis, age <2 or >10 years were risk factors. After day 15, 10% of patients died from treatment-related complications with infection as the main cause of death. Risk factors were age <2 or >10 years and treatment according to the NOPHO-AML-88 protocol. The number of EDs and TRDs in AML is high. Therefore optimal antifungal prophylaxis is essential, and studies on the benefit of antibacterial prophylaxis and individual risk factors for ED and TRD are needed. : NO MORE UNTIL JAN 2005 (Hasle, Henrik) lene.molgaard@dadlnet.dk (Molgaard-Hansen, Lene) merja.mottonen@ppshp.fi (Mottonen, Merja) heidi.glosli@rikshospitalet.no (Glosli, Heidi) gudmkj@talnet.is (Jonmundsson, Gu?mundur K.) jonas.abrahamsson@vgregion.se (Abrahamsson, Jonas) hasle@dadlnet.dk (Hasle, Henrik) Aarhus University Hospital Skejby, Department of Paediatrics - Aarhus - DENMARK (Molgaard-Hansen, Lene) University Hospital, Oulu, Department of Paediatrics - Oulu - FINLAND (Mottonen, Merja) Oslo University Hospital, Rikshospitalet, Department of Paediatrics - Oslo - NORWAY (Glosli, Heidi) Landspitalinn University Hospital, Reykjavik, Department of Paediatrics - Reykjavik - ICELAND (Jonmundsson, Gu?mundur K.) The Queen Silvia Children?s Hospital, Department of Paediatric Oncology - Gothenburg - SWEDEN (Abrahamsson, Jonas) Aarhus University Hospital Skejby, Department of Paediatrics - Aarhus - DENMARK (Hasle, Henrik) DENMARK FINLAND ICELAND NORWAY SWEDEN Other/Unknown Material Iceland The University of Dublin, Trinity College: TARA (Trinity's Access to Research Archive) Norway Silvia ENVELOPE(-57.900,-57.900,-63.300,-63.300) British Journal of Haematology 151 5 447 459 |
institution |
Open Polar |
collection |
The University of Dublin, Trinity College: TARA (Trinity's Access to Research Archive) |
op_collection_id |
fttrinitycoll |
language |
English |
topic |
Medicine |
spellingShingle |
Medicine Early and treatment-related deaths in childhood acute myeloid leukaemia in the Nordic countries: 1984-2003 |
topic_facet |
Medicine |
description |
Abstract Despite major improvements in the cure rate of childhood acute myeloid leukaemia (AML), 5-15% of patients still die from treatment-related complications. In a historical prospective cohort study, we analyzed frequency, clinical features and risk factors for early deaths (ED) and treatment-related deaths (TRD) in 525 children included in the Nordic protocols NOPHO-AML-84, -88 and -93. Seventy patients (13%) died before starting treatment or from treatment-related complications. The death rate rose from 11% in NOPHO-AML-84 to 29% in -88, but then fell to 8% in -93. Sixteen patients (3%) died within the first two weeks, mainly from bleeding or leukostasis. Hyperleukocytosis, age <2 or >10 years were risk factors. After day 15, 10% of patients died from treatment-related complications with infection as the main cause of death. Risk factors were age <2 or >10 years and treatment according to the NOPHO-AML-88 protocol. The number of EDs and TRDs in AML is high. Therefore optimal antifungal prophylaxis is essential, and studies on the benefit of antibacterial prophylaxis and individual risk factors for ED and TRD are needed. : NO MORE UNTIL JAN 2005 (Hasle, Henrik) lene.molgaard@dadlnet.dk (Molgaard-Hansen, Lene) merja.mottonen@ppshp.fi (Mottonen, Merja) heidi.glosli@rikshospitalet.no (Glosli, Heidi) gudmkj@talnet.is (Jonmundsson, Gu?mundur K.) jonas.abrahamsson@vgregion.se (Abrahamsson, Jonas) hasle@dadlnet.dk (Hasle, Henrik) Aarhus University Hospital Skejby, Department of Paediatrics - Aarhus - DENMARK (Molgaard-Hansen, Lene) University Hospital, Oulu, Department of Paediatrics - Oulu - FINLAND (Mottonen, Merja) Oslo University Hospital, Rikshospitalet, Department of Paediatrics - Oslo - NORWAY (Glosli, Heidi) Landspitalinn University Hospital, Reykjavik, Department of Paediatrics - Reykjavik - ICELAND (Jonmundsson, Gu?mundur K.) The Queen Silvia Children?s Hospital, Department of Paediatric Oncology - Gothenburg - SWEDEN (Abrahamsson, Jonas) Aarhus University Hospital Skejby, Department of Paediatrics - Aarhus - DENMARK (Hasle, Henrik) DENMARK FINLAND ICELAND NORWAY SWEDEN |
title |
Early and treatment-related deaths in childhood acute myeloid leukaemia in the Nordic countries: 1984-2003 |
title_short |
Early and treatment-related deaths in childhood acute myeloid leukaemia in the Nordic countries: 1984-2003 |
title_full |
Early and treatment-related deaths in childhood acute myeloid leukaemia in the Nordic countries: 1984-2003 |
title_fullStr |
Early and treatment-related deaths in childhood acute myeloid leukaemia in the Nordic countries: 1984-2003 |
title_full_unstemmed |
Early and treatment-related deaths in childhood acute myeloid leukaemia in the Nordic countries: 1984-2003 |
title_sort |
early and treatment-related deaths in childhood acute myeloid leukaemia in the nordic countries: 1984-2003 |
publisher |
Wiley-Blackwell |
publishDate |
2011 |
url |
http://hdl.handle.net/2262/54894 https://doi.org/10.1111/j.1365-2141.2010.08389.x |
long_lat |
ENVELOPE(-57.900,-57.900,-63.300,-63.300) |
geographic |
Norway Silvia |
geographic_facet |
Norway Silvia |
genre |
Iceland |
genre_facet |
Iceland |
op_relation |
0007-1048 (pISSN) 1365-2141 (eISSN) 00071048 (ISSN) BJH-2010-00926 (PII) BJH-2010-00926.R1 (manuscript) http://hdl.handle.net/2262/54894 British Journal of Haematology 151 5 447 doi:10.1111/j.1365-2141.2010.08389.x BJH (abbrev) |
op_rights |
6 months |
op_doi |
https://doi.org/10.1111/j.1365-2141.2010.08389.x |
container_title |
British Journal of Haematology |
container_volume |
151 |
container_issue |
5 |
container_start_page |
447 |
op_container_end_page |
459 |
_version_ |
1766039182385348608 |